AXON - Axovant Sciences Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development141,412134,77876,644
Selling General and Administrative71,90645,72156,518
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-213,318-180,499-133,162
Income from Continuing Operations
Total Other Income/Expenses Net211-369-369
Earnings Before Interest and Taxes-213,107-180,868-133,162
Interest Expense7,5451,1431,143
Income Before Tax-220,652-182,011-133,162
Income Tax Expense921-1,060-17
Minority Interest---
Net Income From Continuing Ops-221,573-180,951-133,145
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-221,573-180,951-133,145
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-221,573-180,951-133,145